Heart Test Laboratories, Inc. (HSCSW)

US — Healthcare Sector
Peers: HSCS  CLPT  LUCD  PAVM  IINNW  BIAFW 

Automate Your Wheel Strategy on HSCSW

With Tiblio's Option Bot, you can configure your own wheel strategy including HSCSW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HSCSW
  • Rev/Share 0.0039
  • Book/Share 0.1842
  • PB 17.9673
  • Debt/Equity 14.5499
  • CurrentRatio 0.5864
  • ROIC -745.1929

 

  • MktCap 7428682.0
  • FreeCF/Share -3779.0851
  • PFCF -0.0018
  • PE -0.0014
  • Debt/Assets 0.7069
  • DivYield 0
  • ROE -851.5847

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Heart Test Laboratories, Inc. (HSCSW)

  • IPO Date 2022-06-15
  • Website https://heartsciences.com
  • Industry Medical - Devices
  • CEO Andrew Simpson
  • Employees 15
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.